EMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial

MT Newswires Live

Jan 27

EMVision Medical Devices (ASX:EMV) said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.

Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.

At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606559277"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606559277\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606559277?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 13:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606559277","market":"sh","top_or_hot":-1,"title":"EMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial","media":"MT Newswires Live","content":"<html><body><p> EMVision Medical Devices (ASX:EMV) said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.</p><p>Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.</p><p>At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-27 13:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EMVision Medical Devices (ASX:EMV) said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.</p><p>Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.</p><p>At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMV.AU","symbol_name":"EMVISION MEDICAL DEVICES LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2606559277","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606559277","pubTimestamp":1769491233,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EMVision Medical Devices  said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EMV.AU":"EMVISION MEDICAL DEVICES LTD","BK7007":"医疗保健设备"},"translate_title":"EMVision Medical Devices表示，七家医院正在积极招募患者参加护理点脑部扫描仪验证试验","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMV.AU":1},"content_text":"EMVision Medical Devices (ASX:EMV) said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}